Hopp til innhold
NHI.no
Annonse
Informasjon

Behandling av akutt nyresvikt

Behandlingen avhenger av årsaken og foregår i sykehus. Sentralt i behandlingen står væskebehandling. I noen tilfeller er det nødvendig med kunstig rensing av blodet, dialyse.

Nyrer og urinveier
I de tilfeller der det tar tid før nyrefunksjonen normaliserer seg, kan det bli nødvendig å bruke en kunstig nyre for å rense blodet ditt for overskuddsvann og opphopning av avfallsstoffer.

Sist oppdatert:

30. des. 2019

Innhold i artikkelen

Behandling av akutt nyresvikt

Behandling av akutt nyresvikt avhenger delvis av årsaken og delvis av omfanget av svikten. Du vil som regel bli innlagt på en sykehusavdeling som har ekspertise på nyre- eller urinveissykdommer. Ved mindre alvorlige sykdomsbilder vil du bli henvist til spesialist i slike sykdommer.

Annonse

Spesialistens første oppgave er å fastslå hva som er den nøyaktige årsaken til nyresvikten, siden det vil bestemme behandlingen. Dernest må omfanget av opphopning av avfallsstoffer og vann i kroppen din klargjøres, fordi det påvirker beslutninger om hvilke medisiner du skal ha og om det er behov for dialyse, det vil si rensing av blodet ditt gjennom en dialysemaskin.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Nyreskade, akutt . Referanselisten for dette dokumentet vises nedenfor

  1. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest Jul 2004; 114(1): 5-14. PubMed
  2. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114: 5-14. PubMed
  3. Mercado MG, Smith DK, Guard EL. Acute kidney injury: diagnosis and management. Am Fam Physician. 2019 Dec 1;100(11):687-694. . www.aafp.org
  4. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-30. PubMed
  5. Kellum JA, Unruh ML, Murugan R. Acute kidney injury. Clin Evid 2011; 11: 1094-1118.
  6. Kellum JA, Levin N, Bouman CSC, et al. The RIFLE Criteria of Acute Renal Failure. http://www.adqi.net (last accessed 16 January 2004).
  7. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(suppl 1):1–138. kdigo.org
  8. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest Jul 2004; 114: 5-14. PubMed
  9. UK Renal Association. Clinical practice guidelines: acute kidney injury. March 2011. (Accessed 11 May 2017). www.renal.org
  10. Metcalfe W, Simpson M, Khan IH, et al. Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM 2002; 95: 579-83. PubMed
  11. Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis Jul 2008; 15(3): 297-307. PubMed
  12. Hilton R. Acute renal failure. BMJ 2006; 333: 786-90. PubMed
  13. Hartmann A, Midtvedt K, Witczak B. Nyreskader og nyresvikt utløst av legemidler. Tidsskr Nor Lægeforen 2004; 124: 2765-6. PubMed
  14. Bellomo R, Kellum JA, Ronco C, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828. PMID: 28364303 PubMed
  15. Brater DC. Anti-inflammatory agents and renal function. Semin Arthritis Rheum 2002; 32: (suppl 1) 33-42.
  16. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-36. PubMed
  17. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. Aust NZ J Surg 2003; 73: 144-53. PubMed
  18. Gruber SJ, Shapiro CJ. Nephropathy induced by contrast medium. N Engl J Med 2003; 348: 2257-59. New England Journal of Medicine
  19. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ Jan 8 2013; 346: e8525.
  20. Pickering JW, Frampton CM, Walker RJ, et al. Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients. Crit Care. 2012;16(3):R107. PubMed
  21. Perazella MA. The urine sediment as a biomarker of kidney disease. Am J Kidney Dis. 2015;66(5):748–755. PMID: 25943719. PubMed
  22. Podoll A, Walther C, Finkel K. Clinical utility of gray scale renal ultrasound in acute kidney injury. BMC Nephrol. 2013;14:188. PubMed
  23. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004; 15: 1677-89. PubMed
  24. Mishraa J, Dentb C, Tarabishia R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-8. PubMed
  25. Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis. 2018;72(1):136–148. PMID: 29478864. PubMed
  26. Ho KM, Sheridan DJ. Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ 2006; 333: 420-3. British Medical Journal
  27. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-56. New England Journal of Medicine
  28. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-66. PubMed
  29. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422–427. PMID: 19436332. PubMed
  30. Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10(1):37–47. PMID: 24217464. PubMed
  31. D'Intini V, Ronco C, Bonello M, Bellomo R. Renal replacement therapy in acute renal failure. Best Pract Res Clin Anaesthesiol 2004; 18: 145-57. PubMed
  32. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40: 875-85. PubMed
  33. d'Avila DO, Cendoroglo NM, dos Santos OF, Schor N, de Figueiredo CE. Acute renal failure needing dialysis in the intensive care unit and prognostic scores. Ren Fail 2004; 26: 59-68. PubMed
  34. Van Biesen W, Vanholder R, Lameire N. Dialysis strategies in critically ill acute renal failure patients. Curr Opin Crit Care 2003; 9: 491-95. PubMed
  35. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: 598-603. PubMed
  36. Nainggolan L. Two Antihypertensives Plus NSAID Ups Risk of Acute Kidney Injury. Two Antihypertensives Plus NSAID Ups Risk of Acute Kidney Injury. Heartwire. Jan 9 2013; Accessed Jan 14, 2013.
  37. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-69. New England Journal of Medicine
  38. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 2003; 14: 1022-30. PubMed
  39. Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58–66. PMID: 24988558. PubMed
  40. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30: 2051-8. PubMed
  41. Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017;28(1):377–387. PMID: 27297949. PubMed
  42. Vanmassenhove J, Vanholder R, Lameire N. Points of concern in post acute kidney injury management. Nephron. 2018;138(2):92–103. PMID: 29131132. PubMed
Annonse
Annonse